ALPS ADVISORS INC - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$189,893
+7.9%
32,516
+24.1%
0.00%0.0%
Q3 2022$176,000
+57.1%
26,197
-1.8%
0.00%
+100.0%
Q2 2022$112,000
-59.6%
26,665
-51.9%
0.00%
-66.7%
Q1 2021$277,000
-59.1%
55,449
+3.4%
0.00%
-62.5%
Q4 2020$678,000
+82.3%
53,642
+41.8%
0.01%
+60.0%
Q3 2020$372,000
-7.7%
37,841
-6.5%
0.01%0.0%
Q2 2020$403,000
-12.4%
40,455
-22.2%
0.01%
-28.6%
Q1 2020$460,000
+3.1%
51,990
+7.4%
0.01%
+133.3%
Q4 2019$446,000
+59.9%
48,399
+2.1%
0.00%
+50.0%
Q3 2019$279,000
-53.3%
47,419
-4.8%
0.00%
-50.0%
Q2 2019$598,000
-12.4%
49,799
-12.0%
0.00%
-20.0%
Q1 2019$683,000
-38.6%
56,590
-36.1%
0.01%
-44.4%
Q4 2018$1,112,000
-3.1%
88,619
+14.6%
0.01%
+12.5%
Q3 2018$1,147,000
+27.3%
77,297
+44.4%
0.01%
+33.3%
Q2 2018$901,000
-22.7%
53,536
+5.1%
0.01%
-33.3%
Q1 2018$1,166,000
+79.4%
50,929
+102.6%
0.01%
+80.0%
Q4 2017$650,000
+97.0%
25,139
+12.5%
0.01%
+150.0%
Q3 2017$330,000
+16.2%
22,343
+9.7%
0.00%0.0%
Q2 2017$284,000
-13.1%
20,362
+6.3%
0.00%0.0%
Q1 2017$327,000
+48.6%
19,162
-10.5%
0.00%0.0%
Q4 2016$220,000
-23.1%
21,406
-24.5%
0.00%0.0%
Q3 2016$286,000
-18.3%
28,336
-9.2%
0.00%
-33.3%
Q2 2016$350,000
-28.7%
31,210
+20.6%
0.00%
-40.0%
Q4 2015$491,000
-89.9%
25,8710.0%0.01%0.0%
Q3 2015$4,856,00025,8710.01%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Kynam Capital Management, LP 4,420,349$25,814,8383.96%
Parkman Healthcare Partners LLC 1,203,484$7,028,3471.87%
SPHERA FUNDS MANAGEMENT LTD. 1,002,783$5,856,2531.26%
TANG CAPITAL MANAGEMENT LLC 1,150,000$6,716,0000.98%
BVF INC/IL 3,629,000$21,193,3600.89%
Nantahala Capital Management 1,732,388$10,117,1460.66%
AWM Investment Company, Inc. 666,661$3,893,3000.56%
INGALLS & SNYDER LLC 1,295,833$7,5680.41%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 200,800$1,172,6720.36%
Kensington Investment Counsel, LLC 58,599$342,2180.27%
View complete list of CONCERT PHARMACEUTICALS INC shareholders